ATCT-22 NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

Por Lee, Eudocia Q., Zhang, Peixin, Wen, Patrick Y., Gerstner, Elizabeth R., Reardon, David A., Aldape, Ken, de Groot, John F., Choe, Kevin S., Raizer, Jeffrey J., Kim, Lyndon J., Chmura, Steven J., Robins, H. Ian, Connelly, Jennifer, Battiste, James, Villano, John, Wagle, Naveed, Merrell, Ryan T., Wendland, Merideth, Mehta, Minesh P.
Publicado no Neuro Oncol (2015)

NRG/RTOG 1122: phase II double-blinded, placebo-controlled study of bevacizumab with/without trebananib in patients with recurrent glioblastoma or gliosarcoma

Por Lee, Eudocia Q, Zhang, Peixin, Wen, Patrick Y, Gerstner, Elizabeth R, Reardon, David A, Aldape, Kenneth D, deGroot, John F, Pan, Edward, Raizer, Jeffrey J, Kim, Lyndon J, Chmura, Steven J, Robins, H Ian, Connelly, Jennifer M, Battiste, James D, Villano, John L, Wagle, Naveed, Merrell, Ryan T, Wendland, Merideth M, Mehta, Minesh P
Publicado no Cancer (2020)

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Por Liau, Linda M., Ashkan, Keyoumars, Tran, David D., Campian, Jian L., Trusheim, John E., Cobbs, Charles S., Heth, Jason A., Salacz, Michael, Taylor, Sarah, D’Andre, Stacy D., Iwamoto, Fabio M., Dropcho, Edward J., Moshel, Yaron A., Walter, Kevin A., Pillainayagam, Clement P., Aiken, Robert, Chaudhary, Rekha, Goldlust, Samuel A., Bota, Daniela A., Duic, Paul, Grewal, Jai, Elinzano, Heinrich, Toms, Steven A., Lillehei, Kevin O., Mikkelsen, Tom, Walbert, Tobias, Abram, Steven R., Brenner, Andrew J., Brem, Steven, Ewend, Matthew G., Khagi, Simon, Portnow, Jana, Kim, Lyndon J., Loudon, William G., Thompson, Reid C., Avigan, David E., Fink, Karen L., Geoffroy, Francois J., Lindhorst, Scott, Lutzky, Jose, Sloan, Andrew E., Schackert, Gabriele, Krex, Dietmar, Meisel, Hans-Jorg, Wu, Julian, Davis, Raphael P., Duma, Christopher, Etame, Arnold B., Mathieu, David, Kesari, Santosh, Piccioni, David, Westphal, Manfred, Baskin, David S., New, Pamela Z., Lacroix, Michel, May, Sven-Axel, Pluard, Timothy J., Tse, Victor, Green, Richard M., Villano, John L., Pearlman, Michael, Petrecca, Kevin, Schulder, Michael, Taylor, Lynne P., Maida, Anthony E., Prins, Robert M., Cloughesy, Timothy F., Mulholland, Paul, Bosch, Marnix L.
Publicado no J Transl Med (2018)

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Por Liau, Linda M., Ashkan, Keyoumars, Tran, David D., Campian, Jian L., Trusheim, John E., Cobbs, Charles S., Heth, Jason A., Salacz, Michael, Taylor, Sarah, D’Andre, Stacy D., Iwamoto, Fabio M., Dropcho, Edward J., Moshel, Yaron A., Walter, Kevin A., Pillainayagam, Clement P., Aiken, Robert, Chaudhary, Rekha, Goldlust, Samuel A., Bota, Daniela A., Duic, Paul, Grewal, Jai, Elinzano, Heinrich, Toms, Steven A., Lillehei, Kevin O., Mikkelsen, Tom, Walbert, Tobias, Abram, Steven R., Brenner, Andrew J., Brem, Steven, Ewend, Matthew G., Khagi, Simon, Portnow, Jana, Kim, Lyndon J., Loudon, William G., Thompson, Reid C., Avigan, David E., Fink, Karen L., Geoffroy, Francois J., Lindhorst, Scott, Lutzky, Jose, Sloan, Andrew E., Schackert, Gabriele, Krex, Dietmar, Meisel, Hans-Jorg, Wu, Julian, Davis, Raphael P., Duma, Christopher, Etame, Arnold B., Mathieu, David, Kesari, Santosh, Piccioni, David, Westphal, Manfred, Baskin, David S., New, Pamela Z., Lacroix, Michel, May, Sven-Axel, Pluard, Timothy J., Tse, Victor, Green, Richard M., Villano, John L., Pearlman, Michael, Petrecca, Kevin, Schulder, Michael, Taylor, Lynne P., Maida, Anthony E., Prins, Robert M., Cloughesy, Timothy F., Mulholland, Paul, Bosch, Marnix L.
Publicado no J Transl Med (2018)